Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Biocept, Inc.

Biocept, Inc. (BIOC) Stock Overview

Explore Biocept, Inc.’s financial performance, market position, analyst ratings, and future outlook.

BIOC●NASDAQ
HealthcareMedical - Diagnostics & Research
$0.43
$0.00(0.00%)
U.S. Market opens in 12h 45m

Biocept, Inc. (BIOC)

Meyka AI Score

Z

Key Financials

Market Cap450.8K
P/E Ratio-0.01
EPS (TTM)$-48.17
ROE-1.38%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

BIOC Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Biocept, Inc. (NASDAQ: BIOC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Biocept, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BIOC on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Biocept, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.01 and a market capitalization of 450.8K. Combined with our AI analysis, these give both institutional and retail investors a clear view of BIOC on the NASDAQ.

Price Performance (NASDAQ: BIOC)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
-98.31%
5-Year Change
-98.72%
All-Time (Max) Change
-100.00%

Contact Information

https://biocept.com
858 320 8200
9955 Mesa Rim Road, San Diego, CA, 92121

Company Facts

500 Employees
IPO DateFeb 5, 2014
CountryUS

Frequently Asked Questions